Eli – Finance News Today

Eli Lilly LLY cuts 2024 revenue outlook on weight loss drugs

Medicare can cover Eli Lilly’s Zepbound for sleep apnea: Health Department

FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea

Eli Lilly weight loss drug Zepbound no longer in shortage

Eli Lilly releases new, cheaper form of weight loss drug

Eli Lilly weight loss drug cuts risk of developing diabetes in trial

Here’s why Eli Lilly is down heading into earnings — and how to play it

Deutsche Bank says Eli Lilly stock is a buy, in line with our rating

Eli Lilly’s earnings rally is not done yet — plus, why TJX has stayed

Eli Lilly’s blowout quarter should quiet concerns about the stock